1 |
Merlini G, Westermark P. The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies. J Intern Med 2004;255:159-78.
DOI
|
2 |
Lee MH, Lee SP, Kim YJ, Sohn DW. Incidence, diagnosis and prognosis of cardiac amyloidosis. Korean Circ J 2013; 43:752-60.
DOI
|
3 |
Zacek P, Harrer J. Amyloidosis and cardiac surgery. In: Narin C, editor. Perioperative considerations in cardiac surgery [Internet]. Rijeka: InTech; 2012 [cited 2014 Nov 7]. Available from: http://www.intechopen.com/books/perioperative-considerations-in-cardiac-surgery/cardiac-amyloidosisversus- cardiac-surgery.
|
4 |
Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation 2005;112:2047-60.
DOI
|
5 |
Gillmore JD, Wechalekar A, Bird J, et al. Guidelines on the diagnosis and investigation of AL amyloidosis. Br J Haematol 2015;168:207-18.
DOI
|
6 |
Quarta CC, Kruger JL, Falk RH. Cardiac amyloidosis. Circulation 2012;126:e178-82.
DOI
|
7 |
Vanden Driesen RI, Slaughter RE, Strugnell WE. MR findings in cardiac amyloidosis. AJR Am J Roentgenol 2006; 186:1682-5.
DOI
|